These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31663408)

  • 1. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS; Wells S; Patel PP; Koethe BC; Maron BJ
    J Am Heart Assoc; 2019 Nov; 8(21):e012041. PubMed ID: 31663408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
    Meghji Z; Nguyen A; Fatima B; Geske JB; Nishimura RA; Ommen SR; Lahr BD; Dearani JA; Schaff HV
    JAMA Cardiol; 2019 Mar; 4(3):237-245. PubMed ID: 30810698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Lesser JR; Garberich RF; McGriff DM; Maron MS
    Circulation; 2016 Jan; 133(1):62-73. PubMed ID: 26518766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
    Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
    Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
    Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
    J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Olivotto I; Casey SA; Arretini A; Tomberli B; Garberich RF; Link MS; Chan RHM; Lesser JR; Maron BJ
    J Am Coll Cardiol; 2016 Mar; 67(12):1399-1409. PubMed ID: 27012399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    Rowin EJ; Maron BJ; Carrick RT; Patel PP; Koethe B; Wells S; Maron MS
    J Am Coll Cardiol; 2020 Jun; 75(24):3033-3043. PubMed ID: 32553256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
    Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
    J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
    Shirani J; Aurshiya R; Elshaikh A; Olenchock SA; Rowin EJ; Maron MS; Maron BJ
    Am J Cardiol; 2021 Mar; 142():130-135. PubMed ID: 33279482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M
    JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy.
    Pasqualucci D; Fornaro A; Castelli G; Rossi A; Arretini A; Chiriatti C; Targetti M; Girolami F; Corda M; Orrù P; Matta G; Stefàno P; Cecchi F; Porcu M; Olivotto I
    Circ Heart Fail; 2015 Nov; 8(6):1014-21. PubMed ID: 26446673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy.
    Fumagalli C; Zocchi C; Cappelli F; Celata A; Tassetti L; Sasso L; Zampieri M; Argirò A; Marchi A; Targetti M; Berteotti M; Maurizi N; Mori F; Livi P; Baldini K; Tomberli A; Girolami F; Favilli S; Mecacci F; Olivotto I
    Eur J Prev Cardiol; 2024 Jan; 31(1):3-10. PubMed ID: 37531614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex on clinical outcomes of hypertrophic cardiomyopathy in Singapore.
    Li TY; Yeo S; Ngiam NJ; Lee CH; Low TT; Lim YC; Evangelista LKM; Lee EC; Sari NY; Yeo TC; Yip JW; Poh KK; Kong WK; Lin W; Sia CH; Wong RC
    Ann Acad Med Singap; 2023 Jul; 52(7):348-355. PubMed ID: 38904500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
    J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.